前收市價 | 24.01 |
開市 | 23.94 |
買盤 | 0.00 x 1800 |
賣出價 | 0.00 x 2200 |
今日波幅 | 23.80 - 24.02 |
52 週波幅 | 21.53 - 33.09 |
成交量 | |
平均成交量 | 964,142 |
市值 | 10.526B |
Beta 值 (5 年,每月) | 0.51 |
市盈率 (最近 12 個月) | 39.73 |
每股盈利 (最近 12 個月) | 0.60 |
業績公佈日 | 無 |
遠期股息及收益率 | 0.75 (3.15%) |
除息日 | 2024年4月01日 |
1 年預測目標價 | 31.50 |
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes. I think that investing in robotic surgery stocks is an underrated thematic choice for investors. The reason being is that there is currently a very low industry penetration of using robots in the surgical market, which means ther
Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript February 28, 2024 Smith & Nephew plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Deepak Nath: Good morning and welcome to the Smith & Nephew Q4 and Full Year ‘23 […]